SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Mizuho Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $29

Mizuho maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $34 to $29.

Benzinga · 05/07/2020 15:35

Mizuho maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $34 to $29.